Patents by Inventor Saori OHMAE

Saori OHMAE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ameliorative agent for cytokine release syndrome and so on
    Patent number: 11744830
    Abstract: [Problem to be Solved] The present invention provides a medicament for cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis or Langerhans cell histiocytosis. [Means to Solve the Problem] The present invention provides a medicament for at least one selected from the group consisting of cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis, wherein the medicament comprises a compound represented by the following formula I: or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: September 5, 2023
    Assignee: TORII PHARMACEUTICAL CO., LTD.
    Inventors: Yoshihiro Watanabe, Yoshio Tahara, Keisuke Suzuki, Takayuki Mimura, Saori Ohmae
  • AMELIORATIVE AGENT FOR CYTOKINE RELEASE SYNDROME AND SO ON
    Publication number: 20210128550
    Abstract: [Problem to be Solved] The present invention provides a medicament for cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis or Langerhans cell histiocytosis. [Means to Solve the Problem] The present invention provides a medicament for at least one selected from the group consisting of cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis, wherein the medicament comprises a compound represented by the following formula I: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 29, 2019
    Publication date: May 6, 2021
    Applicant: TORII PHARMACEUTICAL CO., LTD.
    Inventors: Yoshihiro WATANABE, Yoshio TAHARA, Keisuke SUZUKI, Takayuki MIMURA, Saori OHMAE